Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized-controlled Trial of a Combined vs. Conventional Percutaneous Intervention for Near-Infrared Spectroscopy Defined High-Risk Native Coronary Artery Lesions

NCT02601664 is registered in ClinicalTrials.gov with North Texas Veterans Healthcare System as lead sponsor.

NCT NCT02601664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized-controlled Trial of a Combined vs. Conventional Percutaneous Intervention for Near-Infrared Spectroscopy Defined High-Risk Native Coronary Artery Lesions
Lead sponsor
North Texas Veterans Healthcare System
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2015
Completion date
February 29, 2016
Enrollment
3 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis, coronary artery disease, near-infrared spectroscopy, peri-procedural myocardial infarction